[Efficacy and safety of half-dose rituximab in the treatment of 23 cases with lupus nephritis].

MLA

Zhao, Y. R., et al. “[Efficacy and Safety of Half-Dose Rituximab in the Treatment of 23 Cases with Lupus Nephritis].” Zhonghua Nei Ke Za Zhi, vol. 62, no. 1, Jan. 2023, pp. 84–87. EBSCOhost, https://doi.org/10.3760/cma.j.cn112138-20220214-00105.

APA

Zhao, Y. R., Li, K. P., Deng, X. H., Liu, X. F., Liao, S. M., Yang, J. S., Zheng, X., Zhang, J. L., Huang, F., & Zhu, J. (2023). [Efficacy and safety of half-dose rituximab in the treatment of 23 cases with lupus nephritis]. Zhonghua Nei Ke Za Zhi, 62(1), 84–87. https://doi.org/10.3760/cma.j.cn112138-20220214-00105

Chicago

Zhao, Y R, K P Li, X H Deng, X F Liu, S M Liao, J S Yang, X Zheng, J L Zhang, F Huang, and J Zhu. 2023. “[Efficacy and Safety of Half-Dose Rituximab in the Treatment of 23 Cases with Lupus Nephritis].” Zhonghua Nei Ke Za Zhi 62 (1): 84–87. doi:10.3760/cma.j.cn112138-20220214-00105.